Articles about LumiThera

Eye care giant Alcon acquires LumiThera, a Seattle-area startup behind device that treats vision loss

LumiThera’s key innovation is a device for use by ophthalmologists that improves vision and slows its loss, with a focus on patients with dry age-related macular degeneration. Read More

Life sciences news roundup: COVID-19 vaccines developed in Seattle get green light, and more

Two COVID-19 vaccines developed in Seattle got the nod from regulatory agencies outside the U.S. this week. A University of… Read More

Medical device startup LumiThera raises $14M to further develop treatment for ocular disorders

LumiThera, the Poulsbo, Wash.-based medical device startup developing a treatment for ocular disorders and diseases, has raised $14 million in… Read More

LumiThera raises cash for medical device that uses light to fight vision loss

Medical device startup LumiThera raised $1.15 million as part of a new fundraising round, according to a new SEC filing.… Read More